Gleason score 8-10 prostatic adenocarcinoma: Prognostic influence in the biochemical progression free survival;Adenocarcinoma de próstata gleason clínico 8-10: Influencia pronóstica enla supervivencia libre de progresión bioquímica

Actas Urologicas Espanolas

Volumn 32, Issue 8, 2008, Pages 792-798

  Rioja Zuazu, J ^a   Zudaire Berbera, J J ^a   Rincon Mayans A ^a   Rosell Costa, D ^a   Robles Garcia, J E ^a   Berian Polo, J M ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

Gleason 8 10; Progression free survival; Prostate cancer

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADENOCARCINOMA; ARTICLE; BIOPSY; BLOOD; COMPARATIVE STUDY; DISEASE FREE SURVIVAL; HUMAN; MALE; PATHOLOGY; PROGNOSIS; PROSTATE TUMOR; SENSITIVITY AND SPECIFICITY;

ADENOCARCINOMA; BIOPSY; DISEASE-FREE SURVIVAL; HUMANS; MALE; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; SENSITIVITY AND SPECIFICITY;

EID: 58149392569     PISSN: 02104806     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0210-4806(08)73937-8     Document Type: Article

References (37)

1. Wingo PA, Tong T, Bolden S. Cancer statistics, 1995. CA Cancer J Clin. 1995;45(1):8-30.
2. Adolfsson J, Steineck G, Whitmore WF Jr. Recent results on management of palpable clinically localized prostate cancer. Cancer. 1993;72(2):310-322.
3. Zincke H, Bergstralh EJ, Blute ML, Myers RP, Barrett DM, Lieber MM, et al. Radical prostatectomy for clinically localized prostate cancer: long-term results of 1,143 patients from a single institution. J Clin Oncol. 1994;12(11):2254-2263.
4. Lu-Yao GL, McLerran D, Wasson J, Wennberg JE. An assessment of radical prostatectomy. Time trends, geographic variation, and outcomes. JAMA. 1993;269(20):2633-2636.
5. Grossfeld GD, Latini DM, Lubeck DP, Broering JM, Li YP, Mehta SS, et al. Predicting disease recurrence in intermediate and high-risk patients undergoing radical prostatectomy using percent positive biopsies: results from CaPSURE. Urology. 2002;59(4):560-565.
6. D'Amico AV, Whittington R, Malkowicz SB, Weinstein M, Tomaszewski JE, Schultz D, et al. Predicting prostate specific antigen outcome preoperatively in the prostate antigen era. J Urol. 2001;166 (6):2185-2188.
7. Paulson DF, Piserchia PV, Gardner W. Predictors of lymphatic spread in prostatic adenocarcinoma: uro-oncology research group study. J Urol. 1980;123(5):697-699.
8. Sogani PC, Israel A, Lieberman PH, Lesser ML, Whitmore WF Jr. Gleason grading of prostate cancer: a predictor of survival. Urology. 1985;25(3):223-227.
9. Perrotti M, Rabbani F, Russo P, Solomon MC, Fair WR. Early prostate cancer detection and potential for surgical cure in men with poorly differentiated tumors. Urology. 1998;52(1):106-110.
10. Lau WK, Bergstralh EJ, Blute ML, Slezak JM, Zincke H. Radical prostatectomy for pathological Gleason 8 or greater prostate cancer: influence of concomitant pathological variables. J Urol. 2002;167(1): 117-122.
11. Borque A, Sanz G, Allepuz C, Plaza L, Gil P, Rioja LA. The use of neural networks and logistic regression analysis for predicting pathological stage in men undergoing radical prostatectomy: a population based study. J Urol. 2001;166(5):1672-1678.
12. Kattan MW, Wheeler TM, Scardino PT. Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer. J Clin Oncol. 1999;17(5):1499-1507.
13. Partin AW, Yoo J, Carter HB, Pearson JD, Chan DW, Epstein JI, et al. The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. J Urol. 1993;150(1):110-114.
14. D'Amico AV, Whittington R, Malkowicz SB, Fondurulia J, Chen MH, Kaplan I, et al. Pretreatment nomogram for prostate-specific antigen recurrence after radical prostatectomy or external-beam radiation therapy for clinically localized prostate cancer. J Clin Oncol. 1999; 17(1):168-172.
15. Allepuz Losa C, Borque Fernando A, Rioja Sanz LA. ¿Cuál es el algoritmo diagnóstico más apropiado para el cribado del cáncer de próstata?. Actas Urol Esp. 2005;29(5):465-472.
16. Oefelein MG, Grayhack JT, McVary KT. Survival after radical retropubic prostatectomy of men with clinically localized high grade carcinoma of the prostate. Cancer. 1995;76(12):2535-2542.
17. Gleason DF. Classification of prostate carcinomas. Cancer Chemother Report. 1966;50(3):125-128.
18. Catalona WJ, Smith DS. 5-year tumor recurrence rates after anatomical radical retropubic prostatectomy for prostate cancer. J Urol. 1994;152(5 Pt 2):1837-1842.
19. Zincke H, Oesterling JE, Blute ML, Bergstralh EJ, Myers RP, Barrett DM. Long-term (15 years) results after radical prostatectomy for clinically localized (stage T2c or lower) prostate cancer. J Urol. 1994; 152(5 Pt 2):1850-1857.
20. Walsh PC, Partin AW, Epstein JI. Cancer control and quality of life following anatomical radical retropubic prostatectomy: results at 10 years. J Urol. 1994;152(5 Pt 2):1831-1836.
21. Grossfeld GD, Chang JJ, Broering JM, Li YP, Lubeck DP, Flanders SC, et al. Under staging and under grading in a contemporary series of patients undergoing radical prostatectomy: results from the Cancer of the Prostate Strategic Urologic Research Endeavor database. J Urol. 2001;165(3):851-856.
22. Walsh PC. Anatomic radical prostatectomy: evolution of the surgical technique. J Urol. 1998;160(6 Pt 2):2418-2424.
23. True LD. Surgical pathology examination for the prostate gland: practice survey by the American Society of Clinical Pathologist. Am J Clin Pathol. 1994;102(5):572-579.
24. Carvalhal GF, Humphrey PA, Thorson P, Yan Y, Ramos CG, Catalona WJ. Visual estimate of the percentage of carcinoma is an independent predictor of prostate carcinoma recurrence after radical prostatectomy. Cancer. 200015;89(6):1308-1314.
25. Amling CL, Bergstralh EJ, Blute ML, Slezak JM, Zincke H.. Defining prostate specific antigen progression after radical prostatectomy: what is the most appropriate cut point?. J Urol. 2001;165(4):1146-1151.
26. Grossfeld GD, Latini DM, Lubeck DP, Mehta SS, Carroll PR. Predicting recurrence after radical prostatectomy for patients with high risk prostate cancer. J Urol. 2003;169(1):157-163.
27. Mian BM, Troncoso P, Okihara K, Bhadkamkar V, Johnston D, Reyes AO. Outcome of patients with Gleason score 8 or higher prostate cancer following radical prostatectomy alone. J Urol. 2002;167(4):1675-1680.
28. Ohori M, Goad JR, Wheeler TM, Eastham JA, Thompson TC, Scardino PT. Can radical prostatectomy alter the progression of poorly differentiated prostate cancer?. J Urol. 1994;152(5 Pt 2): 1843-1849.
29. Partin AW, Lee BR, Carmichael M, Walsh PC, Epstein JI. Radical prostatectomy for high grade disease: a reevaluation 1994. J Urol. 1994;151(6):1583-1586.
30. Manoharan M, Bird VG, Kim SS, Civantos F, Soloway MS. Outcome after radical prostatectomy with a pretreatment prostate biopsy Gleason score of ≥8. BJU Int. 2003;92(6):539-544.
31. Tefilli MV, Gheiler EL, Tiguert R, Banerjee M, Sakr W, Grignon D, et al. Role of radical prostatectomy in patients with prostate cancer of high Gleason score. Prostate. 1999 Apr 1;39(1):60-66.
32. Bastian PJ, Gonzalgo ML, Aronson WJ, Terris MK, Kane CJ, Amling CL, et al.: Clinical and pathologic outcome after radical prostatectomy for prostate cancer patients with preoperativee Gleason sum of 8 to 10. Cancer. 2006;107(6):1265-1272.
33. Berglund RK, Jones JS, Ulchaker JC, Fergany A, Gill I, Kaouk J, et al.: Radical prostatectomy as primary treatment modality for locally advanced prostate cancer: a prospective analysis. Urology. 2006;67 (6):1253-1256.
34. Zagars GK, Ayala AG, von Eschenbach AC, Pollack A. The prognostic importance of Gleason grade in prostatic adenocarcinoma: a long-term follow-up study of 648 patients treated with radiation therapy. Int J Radiat Oncol Biol Phys. 1995;31(2):237-245
35. Kupelian P, Katcher J, Levin H, Zippe C, Suh J, Macklis R, et al. External beam radiotherapy versus radical prostatectomy for clinical stage T1-2 prostate cancer: therapeutic implications of stratification by pretreatment PSA levels and biopsy Gleason scores. Cancer J Sci Am. 1997;3(2):78-87.
36. Do TM, Parker RG, Smith RB, Kagan AR. High-grade carcinoma of the prostate: a comparison of current local therapies. Urology. 2001;57(6):1121-1126.
37. Hurwitz MD, Schultz D, Richie JP, Wein AJ, Whittington R, Malkowicz SB, et al. Radical Prostatectomy for high-grade prostate cancer. Urology. 2006;68(2):367-370.